Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

Semaglutide: FDA approves weight loss jab to treat severe liver disease. | Pepdox

Home
Search
PMID 40841128

Semaglutide: FDA approves weight loss jab to treat severe liver disease.

BMJ (Clinical research ed.)2025PMID: 40841128

View on PubMed DOI: 10.1136/bmj.r1788

Authors

Bowie, Kate